Overview

Biological Effect of Warfarin on Pancreatic Cancer

Status:
Withdrawn
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study aims to asses the effect of warfarin on markers of AXL pathway in patients with pancreatic adenocarcinoma.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Warfarin